Vikas Singh MD FACC FSCAI (@vikmd1026) 's Twitter Profile
Vikas Singh MD FACC FSCAI

@vikmd1026

Structural Interventional Cardiologist #TAVR #Mitraclip #LAA closure #PERT #PFO #CHIP #radialfirst #MGHHeartHealth trained

ID: 151566738

linkhttps://www.researchgate.net/profile/Vikas_Singh15 calendar_today03-06-2010 18:15:31

837 Tweet

2,2K Followers

955 Following

MyJSCAI (@myjscai) 's Twitter Profile Photo

Transcatheter edge-to-edge repair (TEER) grew 2014-18 w/ improved outcomes & lower costs & length of stay. Readmission unchanged at 30-day, trend toward increase at 90 & 180 days. onlinelibrary.wiley.com/doi/full/10.10… x.com/ccijournal, facebook.com/ccijournal, instagram.com/ccijournal

Transcatheter edge-to-edge repair (TEER) grew 2014-18 w/ improved outcomes & lower costs & length of stay. Readmission unchanged at 30-day, trend toward increase at 90 & 180 days.

onlinelibrary.wiley.com/doi/full/10.10…

x.com/ccijournal, facebook.com/ccijournal, instagram.com/ccijournal
Poonam Velagapudi (@pooh_velagapudi) 's Twitter Profile Photo

Challenges w/ dev of valves for TMVR! & How can future systems achieve universal adoption? 🌟Design adaptable to multiple sizes & anatomical variability 🌟Mechanical performance in real world anatomy 🌟Delivered in low profile high performance catheters 🌟Evolution of imaging

Challenges w/ dev of valves for TMVR! 
&
How can future systems achieve universal adoption?

🌟Design adaptable to multiple sizes & anatomical variability
🌟Mechanical performance in real world anatomy
🌟Delivered in low profile high performance catheters
🌟Evolution of imaging
American College of Cardiology (@accintouch) 's Twitter Profile Photo

The PROTECTED TAVR trial showed that routine use of a CEP device does not result in a lower risk of #stroke within 72 hours among patients undergoing transfemoral #TAVR for #vhdAS. Find out more: bit.ly/3xvPsiL #TCT2022 Dr. Deepak L. Bhatt

The PROTECTED TAVR trial showed that routine use of a CEP device does not result in a lower risk of #stroke within 72 hours among patients undergoing transfemoral #TAVR for #vhdAS. Find out more: bit.ly/3xvPsiL #TCT2022 <a href="/DLBHATTMD/">Dr. Deepak L. Bhatt</a>
Poonam Velagapudi (@pooh_velagapudi) 's Twitter Profile Photo

RADIANCE II trial shows statistically & clinically significant ⬇️ in daytime ambulatory SBP & 24h nighttime, home, & office SBP w/ endovascular #uRDN compared w/ sham! No MAE at 30d! Ajay Kirtane #LBCT #TCT2022 Cardiovascular Research Foundation TCT Conference JACC Journals Sahil A. Parikh, MD kenneth rosenfield

RADIANCE II trial shows statistically &amp; clinically significant ⬇️ in daytime ambulatory SBP &amp; 24h nighttime, home, &amp; office SBP w/ endovascular #uRDN compared w/ sham! No MAE at 30d! <a href="/ajaykirtane/">Ajay Kirtane</a> #LBCT #TCT2022 <a href="/crfheart/">Cardiovascular Research Foundation</a> <a href="/TCTConference/">TCT Conference</a> <a href="/JACCJournals/">JACC Journals</a> <a href="/sahilparikhmd/">Sahil A. Parikh, MD</a> <a href="/krosenfieldMD/">kenneth rosenfield</a>
C. Michael Gibson MD (@cmichaelgibson) 's Twitter Profile Photo

Mechanical thrombectomy using FlowTriever System for intermediate- to high-risk PE patients who don't fit conventional criteria for intervention was safe, associated with immediate hemodynamic and symptom benefits, the FLASH registry showed #TCT2022

Mechanical thrombectomy using FlowTriever System for intermediate- to high-risk PE patients who don't fit conventional criteria for intervention was safe, associated with immediate hemodynamic and symptom benefits, the FLASH registry showed #TCT2022
Poonam Velagapudi (@pooh_velagapudi) 's Twitter Profile Photo

#SYMPLICITY HTN-3 trial shows significant ⬇️ in office & 24h ambulatory SBP to 3yrs w/ RDN compared w/ sham, independent of meds! Potential confounding factors may have played a role.. No late emerging complications.. #TCT2022 #LBCT Cardiovascular Research Foundation TCT Conference Dr. Deepak L. Bhatt #ACCIC

#SYMPLICITY HTN-3 trial shows significant ⬇️ in office &amp; 24h ambulatory SBP to 3yrs w/ RDN compared w/ sham, independent of meds! Potential confounding factors may have played a role.. No late emerging complications.. #TCT2022 #LBCT <a href="/crfheart/">Cardiovascular Research Foundation</a> <a href="/TCTConference/">TCT Conference</a> <a href="/DLBHATTMD/">Dr. Deepak L. Bhatt</a> #ACCIC
Davide Capodanno (@dfcapodanno) 's Twitter Profile Photo

The drug of the day is Tong Xin Lou, winner in CTS-AMI at #AHA with a 36% relative risk reduction in MACCE at 30 days in STEMI patients. A capsule includes ginseng, leeches, scorpions, red peony root, three types of earthworms, sandalwood, frankincense, suan zao ren and borneol.

Abdulla A. Damluji, MD, PhD (@drdamluji) 's Twitter Profile Photo

In summary, the pharmacologic Rx for HFpEF starts with SGLT2i: +/- loop diuretics +/- MRA +/- ARNI +/- ARB (cannot take ARNI) Will continue with thread # 6 starting from #49: Non pharamcologic Rx and Mx of multiple chronic conditions. Sorry for many threads.

In summary, the pharmacologic Rx for HFpEF starts with SGLT2i: 

+/- loop diuretics 
+/- MRA
+/- ARNI 
+/- ARB (cannot take ARNI)

Will continue with thread # 6 starting from #49: Non pharamcologic Rx and Mx of multiple chronic conditions. 

Sorry for many threads.
Abdulla A. Damluji, MD, PhD (@drdamluji) 's Twitter Profile Photo

P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events: JACC Journals *** Great - this is what AHA Science recommended for older higher risk patients: Michael Nanna 25-point summary in am report: (they are short sentences 😱) 👇👇👇

P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events: <a href="/JACCJournals/">JACC Journals</a> 

*** Great - this is what <a href="/AHAScience/">AHA Science</a> recommended for older higher risk patients: <a href="/MichaelGNanna/">Michael Nanna</a> 

25-point summary in am report: (they are short sentences 😱) 

👇👇👇
Vikas Singh MD FACC FSCAI (@vikmd1026) 's Twitter Profile Photo

Senior investigators, academic cardiologists take note. Promote your fellows/residents/students. Let them shine! That’s real mentorship.